| # | Drug | Count |
|---|---|---|
| 0 | CABOZANTINIB | 4 |
| 1 | CARBOPLATIN | 4 |
| 2 | FERROUS SULFATE | 4 |
| 3 | NIVOLUMAB | 4 |
| 4 | PACLITAXEL | 4 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 4 |
| 6 | ACETAMINOPHEN | 3 |
| 7 | CISPLATIN | 3 |
| 8 | FUROSEMIDE | 3 |
| 9 | LEVOTHYROXINE SODIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 1 | PORFIMER SODIUM | 1 | 0.0029 |
| 2 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 3 | PORACTANT ALFA | 1 | 0.0014 |
| 4 | SELENIUM SULFIDE | 1 | 0.0011 |
| 5 | ISOFLURANE | 2 | 0.0010 |
| 6 | POTASSIUM IODIDE | 1 | 0.0007 |
| 7 | NITROUS OXIDE | 1 | 0.0005 |
| 8 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 9 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Surfactant [EPC] | 1 | 0.0009 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | General Anesthetic [EPC] | 2 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 8 | 0.0000 |